Skip to main navigation Skip to search Skip to main content

Validation of Amharic versions of medication adherence tools among outpatients with cardiovascular diseases: a cross-sectional study

  • Henok Getachew Tegegn
  • , Stuart Wark
  • , Edouard Tursan d’Espaignet
  • , Joy Spark

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This study aims to validate the Amharic version of the Adherence to Refills and Medication Scale (ARMS-Am) and Morisky Green Levine Scale (MGLS-Am) and compare their psychometric properties among outpatients with cardiovascular diseases (CVD) in Ethiopia.

Methods: Outpatients with CVD attending an Ethiopian general hospital were recruited for this cross-sectional study. Exploratory factor anal-ysis (EFA) and confirmatory factor analysis (CFA) on split samples, internal consistency (IC), convergent validity, known group validity (KGV), and clinical validity using area under the curve (AUC curve) based on blood pressure (BP) control were evaluated.

Key findings: There were 613 participants with a mean age of 57.6 ± 14.1; 56.6% were female. A stepwise-EFA and first-order CFA yielded a 9-item ARMS with a 3-factor solution (explaining 50% of total variance). Second-order CFA confirmed ARMS-9Am is unidimensional (overall IC, α = 0.74). There was a strong correlation (ρ = 0.74) between ARMS-9Am and MGLS-Am scores. Pill count had moderate correlation with ARMS-9Am (ρ = −0.42) and MGLS-Am (ρ = −0.32). Both tools had good KGV for discriminating between groups based on control of BP, lipids, and heart failure symptoms. Based on BP control MGLS-Am (AUC = 0.74) had lower discriminatory power than ARMS-9Am (AUC = 0.81). ARMS-9Am had good clinical validity with 87.8% specificity and 70.4% sensitivity for a score of less than 10.

Conclusion: ARMS-9Am with a cut-off point of < 10 for adherence is a valid tool for measuring medication adherence for people living with CVD and had more robust psychometric properties than MGLS-Am.

Original languageEnglish
Article numberrmae030
Pages (from-to)1-12
JournalJournal of Pharmaceutical Health Services Research
Volume16
Issue number1
Early online date3 Feb 2025
DOIs
Publication statusPublished - 31 Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Validation of Amharic versions of medication adherence tools among outpatients with cardiovascular diseases: a cross-sectional study'. Together they form a unique fingerprint.

Cite this